A phase I-II clinical trial of the anti-CD74 monoclonal antibody milatuzumab in frail patients with refractory chronic lymphocytic leukaemia: A patient based approach
Haran, Michal, Mirkin, Vita, Braester, Andrei, Harpaz, Nurith, Shevetz, Olga, Shtreiter, Marina, Greenberg, Shulamit, Mordich, Orly, Amram, Orna, Binsky-Ehrenreich, Inbal, Marom, Ayelet, Shachar, IditLanguage:
english
Journal:
British Journal of Haematology
DOI:
10.1111/bjh.14726
Date:
May, 2017
File:
PDF, 180 KB
english, 2017